Skip to main content
. Author manuscript; available in PMC: 2014 Jul 3.
Published in final edited form as: Am J Geriatr Psychiatry. 2013 Feb 6;22(5):465–480. doi: 10.1016/j.jagp.2012.08.012

TABLE 4.

Medications and Cognitive Impairment

Study Study Design Population or Exposure Sample Size Findings/Comments
Coluccia 200891 Placebo-controlled, crossover Chronic prednisone vs. controls 24 -Chronic low dose prednisone treatment did not lead to significant memory impairment compared to controls
-Patients with acute administration of steroid medication did have memory impairment
Brown 200786 Prospective Chronic prednisone vs. controls 13 - Cognitive impairment occurring after initiation of prednisone did not lead to further decline over 4 years
Wolf 200184 Placebo-controlled, crossover Young vs. older 20 - Both young and elderly subjects had transient impairments in short term recall with high dose hydrocortisone
Keenan 199685 Cross-sectional (1) and prospective (2) Chronic predisone vs. controls 50 (1) and 25 (2) - Patients on chronic prednisone had more impairments in explicit memory and this was even more significant in elderly subjects
- After 3 months, of acute prednisone therapy months, there were significant changes in short-term memory from baseline
Varney 198487 Case series Acute prednisone 6 - Patients developed cognitive impairment after treatment with prednisone that persisted three to eleven months after discontinuation